The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of "“Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer”.
No. |
Publication Date |
Citing Article |
1 |
2024 |
Yifan Hou, Zhenhua Zhao, Pan Li, Yujia Cao, Yi Zhang, Changsheng Guo, Xiaobo Nie, Junqing Hou. Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024; 1879: 189186189186. https://doi.org/10.1016/j.bbcan.2024.189186 |
2 |
2024 |
Vignesh Sivaganesh, Tram M. Ta, Bela Peethambaran. Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway, International Journal of Molecular Sciences. 2024; 25: 7003. https://doi.org/10.3390/ijms25137003 |
3 |
2024 |
Lin Li, Weixue Huang, Xiaomei Ren, Zhen Wang, Ke Ding, Linxiang Zhao, Jinwei Zhang. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies, Science China Life Sciences. 2024; 67: 2603. https://doi.org/10.1007/s11427-024-2685-9 |